# Dr. Lal PathLabs Ltd (LALPATHLAB)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹1630.1
Day Change: -3.02%
52W High: ₹1770
52W Low: ₹1272.6
Market Cap: ₹27,374 Cr

## Valuation
P/E: 51.91
P/B: 11.46
EPS: ₹31.58
Book Value: ₹143.09
Dividend Yield: 0.87%

## Returns
1Y Return: 6.95%

## Profitability
ROE: 21.48%
ROCE: 30.99%
Debt/Equity: 0.08
Revenue Growth: 16.6%
Profit Growth: -15.4%
EBITDA Margin: 28.32%
Operating Margin: 20.24%

## About
Dr. Lal PathLabs Ltd is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Dr. Lal PathLabs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-18T22:58:14.934Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:14.934Z
Quant Updated: 2026-05-18T22:58:14.934Z
Sentiment Updated: 2026-05-18T22:58:14.934Z
Financials Status: current
Financials Updated: 2026-05-18T08:31:20.882Z
Financials Last Attempt: 2026-05-18T08:31:20.882Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹660 Cr
Operating Profit: ₹156 Cr (OPM 24%)
Net Profit: ₹96 Cr
Tax: ₹140 Cr

## Annual P&L History
Mar 2016: Rev ₹660Cr | PAT ₹96Cr | OPM 24%
Mar 2017: Rev ₹791Cr | PAT ₹133Cr | OPM 26%
Mar 2018: Rev ₹912Cr | PAT ₹156Cr | OPM 26%

## Balance Sheet (Mar 2016)
Total Assets: ₹475 Cr
Total Liabilities: ₹475 Cr
Borrowings: ₹27 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Brigadier Arvind  Lal, Executive Chairman
- Vandana  Lal, Whole-Time Director
- Shankha  Banerjee, Chief Executive Officer
- Ved Prakash Goel C.A., Group CFO & CEO of International Business
- Jai Prakash Meena, Chief Operating Officer

---
Source: rupiya.io/stocks/lalpathlab
Disclaimer: For research and education only. Not investment advice.